Amneal Pharmaceuticals, LLC et al. vs. Supernus Pharmaceuticals, Inc. et al.
Explore the PTAB proceeding IPR2013-00368 filed by Amneal Pharmaceuticals, LLC et al. on 2013-06-20. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2013-00368
Filing Date
2013-06-20
Accorded Filing Date
2013-06-20
Institution Decision Date
2013-12-17
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2014-12-09
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Amneal Pharmaceuticals, LLC et al.
Represented By
Ellison, Eldoraet alPatent Owner / Respondent
Supernus Pharmaceuticals, Inc. et al.
Represented By
Maebius, Stephenet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 28043 | James Smith | +1 978-341-0036 |
| 30382 | Susan Glovsky | +1 617-607-5995 |
| 31804 | Mary Wakimura | +1 978-202-3214 |
| 32045 | Michael Mcgurk | +1 617-806-6380 |
| 33542 | Alice Carroll | +1 978-341-0036 |
| 36725 | Darrell Wong | +1 978-202-3296 |
| 39302 | Timothy Meagher | +1 978-341-0036 |
| 42122 | Deirdre Sanders | +1 978-341-0036 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 12 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 8,206,740 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,394,406 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,394,405 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,470,364 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,709,478 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2015005725 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2016011388 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2019012568 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2022001604 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 46,096,303 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 54,796,404 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 7,749,532 B2 | US Continuation / Sibling | View Official Patent → |
Amneal Pharamceuticals, LLC et al. v. Supernus Pharmaceuticals, Inc. et al.
Amneal Pharamceuticals, LLC et al. v. Supernus Pharmaceuticals, Inc. et al.